These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24316397)

  • 1. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
    Ziliotto R; Gruca MR; Podder S; Noel G; Ogle CK; Hess DA; DeKoter RP
    Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.
    Kamath MB; Houston IB; Janovski AJ; Zhu X; Gowrisankar S; Jegga AG; DeKoter RP
    Leukemia; 2008 Jun; 22(6):1214-25. PubMed ID: 18354487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality.
    Houston IB; Kamath MB; Schweitzer BL; Chlon TM; DeKoter RP
    Exp Hematol; 2007 Jul; 35(7):1056-68. PubMed ID: 17588474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
    Rosenbauer F; Wagner K; Kutok JL; Iwasaki H; Le Beau MM; Okuno Y; Akashi K; Fiering S; Tenen DG
    Nat Genet; 2004 Jun; 36(6):624-30. PubMed ID: 15146183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination of Myeloid Differentiation with Reduced Cell Cycle Progression by PU.1 Induction of MicroRNAs Targeting Cell Cycle Regulators and Lipid Anabolism.
    Solomon LA; Podder S; He J; Jackson-Chornenki NL; Gibson K; Ziliotto RG; Rhee J; DeKoter RP
    Mol Cell Biol; 2017 May; 37(10):. PubMed ID: 28223367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
    Brown NL; Finnon R; Bulman RA; Finnon P; Moody J; Bouffler SD; Badie C
    Leuk Res; 2011 Jan; 35(1):126-32. PubMed ID: 20638124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia.
    Xu LS; Sokalski KM; Hotke K; Christie DA; Zarnett O; Piskorz J; Thillainadesan G; Torchia J; DeKoter RP
    J Immunol; 2012 Oct; 189(7):3347-54. PubMed ID: 22956576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia.
    Aue G; Du Y; Cleveland SM; Smith SB; Davé UP; Liu D; Weniger MA; Metais JY; Jenkins NA; Copeland NG; Dunbar CE
    Blood; 2011 Oct; 118(17):4674-81. PubMed ID: 21878674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subversion of T lineage commitment by PU.1 in a clonal cell line system.
    Dionne CJ; Tse KY; Weiss AH; Franco CB; Wiest DL; Anderson MK; Rothenberg EV
    Dev Biol; 2005 Apr; 280(2):448-66. PubMed ID: 15882585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML.
    Verbiest T; Bouffler S; Nutt SL; Badie C
    Carcinogenesis; 2015 Apr; 36(4):413-9. PubMed ID: 25750172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts.
    Durual S; Rideau A; Ruault-Jungblut S; Cossali D; Beris P; Piguet V; Matthes T
    Leukemia; 2007 May; 21(5):1050-9. PubMed ID: 17361223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
    Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
    Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
    Houston IB; Huang KJ; Jennings SR; DeKoter RP
    Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
    Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
    J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.
    Tondravi MM; McKercher SR; Anderson K; Erdmann JM; Quiroz M; Maki R; Teitelbaum SL
    Nature; 1997 Mar; 386(6620):81-4. PubMed ID: 9052784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.